Safety And Tolerability Results From The Phase 3B Freedom Trial Of Fedratinib (Fedr), An Oral, Selective Jak2 Inhibitor, In Patients With Myelofibrosis (Mf) Previously Treated With Ruxolitinib (Rux)
Fedratinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety And Tolerability Results From The Phase 3B Freedom Trial Of Fedratinib (Fedr), An Oral, Selective Jak2 Inhibitor, In Patients With Myelofibrosis (Mf) Previously Treated With Ruxolitinib (Rux) ### Output: Fedratinib